Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTiton Regulatory News (TON)

Share Price Information for Titon (TON)

Share Price is delayed by 15 minutes
Get Live Data
80.00    0.00 (0.00%)
Bid:
75.00
Ask:
85.00
Spread: 10.00 (13.333%)
Market Cap: £9.00m
TON Live PriceLast checked at - London Stock Exchange

Intraday Titon Share Chart

Trading Update

29 Nov 2022 07:00

RNS Number : 8469H
Titon Holdings PLC
29 November 2022
Β 

LEI: 213800ZHXS8G27RM1D97

Β 

This announcement contains inside information

29 November 2022

Β 

Titon Holdings Plc

Β 

Trading Update

Β 

Titon Holdings Plc ("Titon", the "Group" or the "Company") provides the following update on the Group's expected results for the year to 30 September 2022 ("FY21/22") and on the outlook for the year to 30 September 2023 ("FY22/23").

FY21/22 results

Trading in UK and Europe through to the end of the FY21/22 period continued in line with the Group's expectations following its update on 22 July 2022, as the Group managed the inflationary environment, the ERP system implementation and the supply chain challenges that were present in FY21/22.

However, as a result of the previously reported weak housing market and shift in market demand to mechanical ventilation products from natural ventilation in the South Korean market, Titon's South Korean business has reported to the Group a further decline in results for FY21/22. As a result, Titon now expects that the Group's overall underlying loss before tax and exceptional items will be moderately larger than previously anticipated.

The Group's financial results for FY21/22 remain subject to the completion of the Group's audit. The Group expects that its final audited results for FY21/22 will be published in January 2023.

Current trading and outlook

Trading in the first two months of the Group's current financial year to 30 September 2023 ("FY22/23") has been in line with our expectations in the UK and Europe.

While supply chain shortages have eased, the Group continues to manage inflationary margin erosion through customer price increases, material cost savings and internal efficiencies. The Group has increased the output of Ventilation Systems products as supply shortages have eased and we have invested to increase capacity for our Hardware products to satisfy the increased demand resulting from the Building Regulation changes in June 2022.

In the UK and Europe, we currently expect to report a loss before tax and exceptional items in H1 FY22/23, but we expect to return to profitability in H2 FY22/23. Whilst FY22/23 results overall will be somewhat lower than our previous expectations, we expect FY22/23 will show a full year improvement in performance when compared to our expected FY21/22 results.

Having filled key management vacancies, we now have a strong and experienced leadership team in place whose focus is to improve business performance. In addition, we have an ongoing strong order book with our customers.

Titon Korea is expected to remain loss-making in FY22/23 due to the challenging market conditions, as the Group has yet to see significant sales of mechanical ventilation products launched in response to the shift in demand in that market.

Strong balance sheet

The Group continues to maintain a healthy balance sheet with no indebtedness. Group cash at 30 September 2022 was Β£1.7m. Following the investment in the Group's inventory holding during FY21/22 in order to mitigate the previous supply chain issues, a strategic focus in FY22/23 will be to reduce our inventory holding to normalised levels, to match order book demand and maximise our liquidity and overall working capital positions.

Β 

Alexandra French, CEO, commented:

"After a challenging year, we are comforted that the UK and Europe business performed in line with our revised expectations and has had a reasonable start to the new financial year. However, we are obviously disappointed to report that overall, the Group's trading performance for the FY21/22 full year will be lower than previously indicated due to the poor performance of our Korean subsidiary.

From a UK and European perspective, we now have a strong leadership team in place who have defined a clear vision for the business, and we are confident that this will enable us to deliver stability and ultimately a return to profit in these regions in H2 FY22/23. Titon Korea's return to profitability is now likely to be in the medium term while it develops its position in the mechanical ventilation market and we are therefore evaluating options for streamlining the corporate structure and operations of the Korean business.

We thank all of our customers for their valued business, and we look forward to returning to our strong levels of customer service. We also thank our employees for their continued hard work and commitment during what has been a difficult year. Despite these difficulties we remain confident in our medium-term future, supported by our strong financial position."

Β 

ENDS

Β 

For further information please contact:

Β 

Titon Holdings Plc

Keith RitchieΒ 

Alexandra French

Β 

Tel: +44 (0)7748 146834

Tel: +44 (0)7949 409132

Β 

Shore Capital (Nominated Adviser and Broker)

Daniel Bush

Tom Knibbs

Tel: +44 (0)20 7408 4090

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTBKFBQCBDDADB
Date   Source Headline
29th Jun 202311:30 amRNSNotification of Major Holdings
28th Jun 20232:00 pmRNSNotification of Major Holdings
6th Jun 20231:40 pmRNSNotification of major holdings
6th Jun 20237:00 amRNSNotification of major holdings
1st Jun 20232:07 pmRNSHolding(s) in Company
31st May 20235:38 pmRNSDirector shareholding
23rd May 202310:20 amRNSAmendment to dividend timetable in interim results
19th May 20237:00 amRNSInterim results for the six months to 31 Mar 2023
18th Apr 20236:10 pmRNSHolding(s) in Company
14th Apr 202312:52 pmRNSIssue of Equity
12th Apr 20235:15 pmRNSNotification of major holdings
11th Apr 20233:40 pmRNSNotification of major holdings
6th Apr 20236:03 pmRNSResignation of Chief Executive Officer
6th Apr 20234:36 pmRNSNotification of Major Holdings
22nd Mar 20234:30 pmRNSResult of AGM
22nd Mar 20237:00 amRNSTrading Update
24th Feb 20239:30 amRNSAnnual Report & AGM notice
26th Jan 20237:11 amRNSAnnual Report & Financial Statements
29th Nov 20227:00 amRNSTrading Update
7th Oct 20223:30 pmRNSNotification of Major Holdings
15th Sep 202211:01 amRNSChange of Board role
6th Sep 20224:30 pmRNSChange of Auditor
10th Aug 20225:15 pmRNSExercise of options and Director/PDMR Shareholding
3rd Aug 20223:00 pmRNSDirector/PDMR Shareholding
22nd Jul 20223:45 pmRNSDirector/PDMR Shareholding
22nd Jul 20227:00 amRNSTrading Update
29th Jun 20225:29 pmRNSGrant of Options and Director/PDMR Shareholding
28th Jun 20223:20 pmRNSHolding(s) in Company
6th Jun 20223:15 pmRNSHolding(s) in Company Update
6th Jun 20223:15 pmRNSHolding(s) in Company Update
12th May 20227:00 amRNSInterim Results for six months to 31 March 2022
22nd Apr 20227:00 amRNSAppointment of CEO
1st Apr 20227:00 amRNSNon-Executive Director and Board changes
23rd Feb 20226:08 pmRNSResult of AGM
22nd Feb 20227:00 amRNSTrading Update
7th Feb 20223:00 pmRNSDirectorate Change
20th Jan 202212:15 pmRNS2021 Annual Report and Notice of AGM
22nd Dec 20217:00 amRNSAppointment of CFO
21st Dec 20217:00 amRNSPreliminary Announcement results year to 30/09/21
14th Dec 20215:22 pmRNSRevised preliminary results announcement date
12th Nov 20214:30 pmRNSDirector/PDMR Shareholding
10th Nov 202112:21 pmRNSChief Executive Officer resignation
24th Sep 20212:11 pmRNSDirector/PDMR Shareholding
9th Sep 20217:00 amRNSDirectorate Change
23rd Jul 202111:15 amRNSDirector/PDMR Shareholding
13th May 20217:00 amRNSUnaudited Interim Results to 31 March 2021
24th Mar 20217:00 amRNSAppointment of CEO
10th Mar 20214:45 pmRNSResult of AGM and Trading Statement
11th Feb 20219:30 amRNS2020 Annual Report and Notice of 2021 AGM
26th Jan 202110:35 amRNSExercise of options and Director/PDMR shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.